Vimarsana
Biggest News Aggregation in the World

Page 4 - Virtual Only News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Virtual Only. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Virtual Only Today - Breaking & Trending Today

American Transplant Congress 2023 Announces Abstracts Now Available to View on ATC Website - Vimarsana News

American Transplant Congress 2023 Announces Abstracts Now Available to View on ATC Website

1,800 abstracts have been accepted to ATC 2023, representing most exciting science in transplantation

Canadian Pacific Railway : Notice of Meeting and Record Date - Form 8-K - Vimarsana News

Canadian Pacific Railway : Notice of Meeting and Record Date - Form 8-K

We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer: ... | March 31, 2023

American Transplant Congress 2023 Opens Early Registration for San Diego In-Person Conference - Vimarsana News

American Transplant Congress 2023 Opens Early Registration for San Diego In-Person Conference

The American Transplant Congress 2023 will be held at the San Diego Convention Center, June 3 - 7, 2023. Sessions also will be live-streamed.

Everglades Coalition to convene the 38th conference - Vimarsana News

Everglades Coalition to convene the 38th conference

The Everglades Coalition will convene its 38th annual conference Jan. 26-28 in Fort Lauderdale with the theme “A Watershed Moment for America’s Everglades.” The conference includes in-person and virtual options.

EISAI TO PRESENT FULL FINDINGS FROM LECANEMAB CONFIRMATORY PHASE 3 CLINICAL TRIAL (CLARITY AD) AND OTHER ALZHEIMER'S DISEASE RESEARCH AT THE 15TH CLINICAL TRIALS ON ALZHEIMER'S DISEASE (CTAD) CONFERENCE - Vimarsana News

EISAI TO PRESENT FULL FINDINGS FROM LECANEMAB CONFIRMATORY PHASE 3 CLINICAL TRIAL (CLARITY AD) AND OTHER ALZHEIMER'S DISEASE RESEARCH AT THE 15TH CLINICAL TRIALS ON ALZHEIMER'S DISEASE (CTAD) CONFERENCE

/PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker findings from the company's...